503 related articles for article (PubMed ID: 22116397)
1. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.
Shirabe K; Mano Y; Muto J; Matono R; Motomura T; Toshima T; Takeishi K; Uchiyama H; Yoshizumi T; Taketomi A; Morita M; Tsujitani S; Sakaguchi Y; Maehara Y
Surg Today; 2012 Jan; 42(1):1-7. PubMed ID: 22116397
[TBL] [Abstract][Full Text] [Related]
2. Individualized precision treatment: Targeting TAM in HCC.
Li Z; Wu T; Zheng B; Chen L
Cancer Lett; 2019 Aug; 458():86-91. PubMed ID: 31129147
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
4. Macrophages as Targets in Hepatocellular Carcinoma Therapy.
Liu YT; Mao ZW; Ding Y; Wang WL
Mol Cancer Ther; 2024 Jun; 23(6):780-790. PubMed ID: 38310642
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
6. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of triggering receptor expressed on myeloid cells 1 inhibits invasion and migration of liver cancer cells by mediating macrophage polarization.
Chen M; Lai R; Lin X; Chen W; Wu H; Zheng Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649843
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.
Zhou TY; Zhou YL; Qian MJ; Fang YZ; Ye S; Xin WX; Yang XC; Wu HH
J Pharmacol Sci; 2018 Oct; 138(2):89-95. PubMed ID: 30340922
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Degroote H; Van Dierendonck A; Geerts A; Van Vlierberghe H; Devisscher L
J Immunol Res; 2018; 2018():7819520. PubMed ID: 30410942
[TBL] [Abstract][Full Text] [Related]
10. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.
Capece D; Fischietti M; Verzella D; Gaggiano A; Cicciarelli G; Tessitore A; Zazzeroni F; Alesse E
Biomed Res Int; 2013; 2013():187204. PubMed ID: 23533994
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages: role in cancer development and therapeutic implications.
Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization.
Ye Y; Xu Y; Lai Y; He W; Li Y; Wang R; Luo X; Chen R; Chen T
J Cell Biochem; 2018 Mar; 119(3):2951-2963. PubMed ID: 29131381
[TBL] [Abstract][Full Text] [Related]
13. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
14. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
16. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.
Wang H; Wang X; Li X; Fan Y; Li G; Guo C; Zhu F; Zhang L; Shi Y
Cancer Lett; 2014 Apr; 345(1):91-9. PubMed ID: 24333724
[TBL] [Abstract][Full Text] [Related]
17. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
18. The CCR2
Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
[TBL] [Abstract][Full Text] [Related]
20. 8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells.
Sun S; Cui Y; Ren K; Quan M; Song Z; Zou H; Li D; Zheng Y; Cao J
Anticancer Agents Med Chem; 2017; 17(2):286-293. PubMed ID: 26845136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]